The Whitehaven Coal Ltd (ASX: WHC) share price is posting further losses on Thursday. This comes as Chinese policymakers look to stabilise surging coal prices.

At the time of writing, the Whitehaven Coal share price is down 2.62% to $2.97.

China’s NDRC to clamp down on coal industry

China’s National Development and Reform Commission (NDRC) said in a statement on 19 October it may adopt “limited profit rates, set price limits and implement other interventional mechanisms such as price declaration system and price adjustment filing system to stabilise thermal coal prices,” according to S&P Global.

“The current price increase has completely deviated from the fundamentals of supply and demand, and the heating season is approaching, and the price is still showing a further irrational upward trend,” the statement said.

Similar to the NDRC’s response to surging iron ore prices, it said it will increase inspections and crack down on illegal activities such as spreading misinformation, price collusion, and hoarding.

Iron ore prices have fallen off a cliff following weak demand from China. However, coal demand is expected to remain elevated ahead of China’s winter and spring seasons.

“There might be some correction but there won’t be a steep drop in prices because China is short on coal [supply]. A steep drop is likely to be seen early next year and not now when it is winter,” said a Singapore-based trader, as reported by S&P Global.

Nonetheless, China’s action has spooked coal investors. Other ASX-listed producers including Yancoal Australia Ltd (ASX: YAL) and New Hope Corporation Limited (ASX: NHC) have also seen their share prices fall. They are down 2.87% and 1.26% respectively.

Whitehaven Coal share price slides to 1-month low

The Whitehaven Coal share price has so far tumbled 8.6% this week and today hit a 1-month low of $2.91 during early trade.

Investors are likely trying to price-in the impact of China’s intervention on its coal markets. After all, China managed to halve iron ore prices following tightening property credit, its Evergrande debt crisis, and weak infrastructure growth.

The post Whitehaven Coal (ASX:WHC) share price falls as China intervenes in coal market appeared first on The Motley Fool Australia.

More reading

• These 3 ASX 200 shares topped the volume charts this Wednesday
• Which ASX 300 shares are the major movers today?
• Why Beach, Flight Centre, Tyro, and Whitehaven Coal are dropping
• Why is the New Hope (ASX:NHC) share price sinking 5% on Wednesday?
• Why the Whitehaven Coal (ASX:WHC) share price is plunging 6% on Wednesday

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3vJe31D

Last week, we took a look at the latest exchange-traded fund (ETF) that looks set to join the ASX boards. ETF provider BetaShares has announced that the ASX boards will soon be graced with the ASX’s first ever cryptocurrency-based ETF. It will be known as the BetaShares Crypto Innovators ETF (ASX: CRYP) and will give investors a way to invest in the ‘blockchain economy’.

As we covered last week, this ETF will be investing in a “portfolio of leading global companies at the forefront of the crypto ecosystem”. BetaShares tells us that this ETF will be designed to “capture the full breadth” of said ecosystem. It will do so by tracking an index that holds a “focused portfolio of more than 230 leading crypto innovators”.

We don’t know too much more than that at this stage. Aside from a teaser that this portfolio currently holds 3 crypto-based companies. These are Coinbase Global Inc (NASDAQ: COIN), Riot Blockchain Inc (NASDAQ: RIOT) and MicroStrategy Incorporated (NASDAQ: MSTR).

BetaShares Crypto Innovators ETF (CRYP) set to hit the ASX ‘soon’

Importantly, this CRYP ETF will not be holding cryptocurrency assets directly. So one won’t be able to use CRYP for direct exposure to cryptocurrencies like Bitcoin (CRYPTO: BTC), Ethereum (CRYPTO: ETH) or Dogecoin (CRYPTO: DOGE).

BetaShares has said this has been done partly to save investors from the “complications of holding digital assets directly”. Instead, the CRYP ETF’s portfolio will give exposure to the companies that are involved in “building crypto mining equipment, crypto trading venues, and other key services that allow the crypto economy to thrive”.

This is in stark contrast to a recent ETF listing over in the US. This new fund does give investors a more direct opportunity to invest in the digital coins themselves, albeit using futures contracts. My Fool colleague Bernd went through this new ETF and its launch in depth yesterday.

So when will ASX investors finally get a chance to invest in the new BetaShares CRYP ETF?

Well, according to the provider, all we are getting at the moment is “soon”. BetaShares implies on its website that the Crypto Innovators ETF has yet to receive “final regulatory approval”. So the launch of this ETF is presumably hinging on that.

I’m sure they’ll be some investors who are champing at the bit. Bitcoin just hit a new all-time high overnight of over US$66,000 per coin. It’s up an incredible 62% over just the past month alone.

The post When will the BetaShares Crypto Innovators ETF (CRYP) list on the ASX? appeared first on The Motley Fool Australia.

More reading

• Whitehaven Coal (ASX:WHC) share price falls as China intervenes in coal market
• Why the BrainChip (ASX:BRN) share price is rocketing 15% today
• Why Robinhood Should Worry About PayPal’s New Payments App
• Epsilon Healthcare (ASX:EPN) share price rockets 24% on new agreement
• Why AMP, Aristocrat, Brainchip, and Healius shares are racing higher

Motley Fool contributor Sebastian Bowen owns shares of Bitcoin, Coinbase Global, Inc., and Ethereum. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Bitcoin and Ethereum. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended MicroStrategy. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3aTbOPA

The BrainChip Holdings Ltd (ASX: BRN) share price is sharply rebounding to a new monthly high following a number of company releases.

At the time of writing, the artificial intelligence (AI) technology company’s shares are up 9% to 49 cents. This means that in the past week, the BrainChip share price has risen by 21.25%.

In earlier trade on Thursday, the BrainChip share price reached 52 cents, up 15% on yesterday’s close.

What did BrainChip announce?

On Thursday morning, BrainChip provided investors with a raft of announcements that are pushing the share price higher.

The first release stated that the company will now begin taking orders of two Akida AI processor development kits. This includes the X86 Shuttle PC development kit as well as an ARM-based Raspberry Pi development kit. Both kits use the AKD1000 chip on a mini-PCI board.

BrainChip’s offering enables customers to begin internal testing and evaluation of Akida’s “high-performance and ultra-low power AI chip”.

BrainChip September quarter update

In the following update, the company released its quarterly activities report for the period ending 30 September.

Receipts from customers for the quarter were US$0.1 million, a decrease of 42% from US$0.2 million in Q2 FY21. While this may appear negative, BrainChip noted that it expects to release the Akida production units and boards to customers in Q4, potentially leading to increased revenues.

Net operating cash outflows came to US$4 million, up from US$3.1 million in Q2 FY21.

BrainChip declared a cash balance of US$23.9 million compared to US$17.7 million in the prior quarter.

BrainChip CEO, Peter van der Made, commented:

The September Quarter marked another major milestone for BrainChip. With the delivery of the first batch of production Akida chips from our design partner Socionext, BrainChip is the world’s first commercial producer of a neuromorphic artificial intelligence chip.

The Company’s two major objectives as we move forward are to focus on building out our sales and marketing organization in preparation for the official commercial launch of the AKD1000 chip and to continue investing in the R&D necessary to bring the next generation of Akida products to market in order to maintain our competitive advantage.

Fifth foundational patent secured

The third release from BrainChip advised that the United States Patents and Trademarks Office has granted another patent.

Titled “Spontaneous Machine Learning and Feature Extraction”, the patent is the fifth foundational patent awarded to BrainChip since 2008.

The patent is intended to protect the unique ability of the Akida chip to learn in real-time, rather than being trained with many samples.

BrainChip stated that intellectual property (IP) security remains a strong focus for preserving its global competitive advantage.

The company is the world’s first commercial producer of neuromorphic AI chips (Akida1000).

BrainChip share price snapshot

The BrainChip share price has gained 27% over the past 12 months and 12% so far in 2021.

BrainChip shares reached a 52-week high of 77 cents in March 2021 then began moving in circles.

BrainChip has a market capitalisation of about $821 million with almost 1.7 billion shares on its registry.

The post Why the BrainChip (ASX:BRN) share price is rocketing 15% today appeared first on The Motley Fool Australia.

More reading

• Why AMP, Aristocrat, Brainchip, and Healius shares are racing higher
• Why has the Brainchip (ASX: BRN) share price tanked 20% in a month?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3vtxCL7

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Robinhood Markets (NASDAQ: HOOD) has added new users at a high rate over the past few years. For the second quarter, net cumulative funded accounts more than doubled to 22.5 million year over year. But the online trading platform could face mounting competition from PayPal Holdings (NASDAQ: PYPL), which just recently launched a new version of its digital app, complete with shopping tools, bill payment, and financial services, in addition to cryptocurrency trading. 

Here’s a look at what PayPal is offering and why it could steal Robinhood’s thunder.  

PayPal is building the ultimate financial services app

Right now, PayPal and Robinhood are two different apps, serving two different groups of customers. PayPal’s app is centered around daily cash management, where you can pay bills, send money to friends, and browse deals from leading retailers. Robinhood is primarily focused on serving long-term investors, traders, and cryptocurrency investors. In the second quarter, Robinhood saw a larger share of new customers trading cryptocurrency rather than stocks for the first time. 

But make no mistake, both companies are on a collision course going after the same market. Robinhood already offers basic cash management features, such as a debit card and the ability to pay bills and receive direct deposits. It’s a sign of where these free trading apps and digital wallets are headed. Juniper Research estimates that the number of people using digital wallets will double to 4.4 billion by 2025. Over time, many people will likely gravitate to one “super” app that does it all — peer-to-peer payments, shopping, bill payment, and investing.

The problem for Robinhood is that PayPal already has a massive installed base of users to easily promote the financial service features of its own app. PayPal ended the second quarter with 403 million active accounts, along with 32 million merchant accounts, which is miles ahead of Robinhood’s 22.5 million. As PayPal continues to launch new features on its app that mirror what these stock trading apps are doing, Robinhood may have a steep uphill climb on its hands. Robinhood’s recent momentum stems from more people trading cryptocurrency, but PayPal is one of the few apps that lets users shop at leading retail brands with their cryptocurrency balance. 

What’s more, PayPal said it plans to launch new investment capabilities on its app in the coming quarters, along with a high-yield savings account option through Synchrony Financial. PayPal’s ability to combine all these features, allowing users to seamlessly use their money to trade cryptocurrency, buy stocks, and take advantage of promotional retail offers in one app might be too much for Robinhood to match in the long run. 

Too much uncertainty in Robinhood’s future

Robinhood still has some ways it can differentiate itself. It is starting to roll out 24/7 phone support and prioritizing investing in educational content. Robinhood also introduced IPO Access earlier this year, allowing users to invest in newly listed companies at their IPO prices. It’s unclear whether PayPal’s new investment offering will be as robust as Robinhood’s app or will be a simplified stock trading interface like Square‘s Cash App.

However, there’s nothing preventing PayPal from eventually offering some of the same features as Robinhood. After all, PayPal has got plenty of cash to reinvest in new features. Over the last year, it generated $4.8 billion in profit, while Robinhood reported half a billion in net losses in the second quarter.  

Beyond the looming threat from PayPal, new regulation by the Securities and Exchange Commission is a risk for Robinhood given its reliance on the controversial “payment for order flow” business model.

Robinhood is facing double threats from the SEC and PayPal’s new app that could make it more difficult for Robinhood to win new users. I would be cautious about paying a high price-to-sales ratio of 21 for Robinhood shares right now. 

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The post Why Robinhood Should Worry About PayPal’s New Payments App appeared first on The Motley Fool Australia.

More reading

• Pinterest stock: Buy, sell, or hold ahead of possible buyout?
• Why PayPal investors got nervous on Wednesday

John Ballard has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended PayPal Holdings. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended the following options: long January 2022 $75 calls on PayPal Holdings. The Motley Fool Australia has recommended PayPal Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

from The Motley Fool Australia https://ift.tt/3vuJCfp

The Epsilon Healthcare Ltd (ASX: EPN) share price is off to the races today, currently up 20% at 15 cents apiece after hitting an intraday high of 16.5 cents at midday.

Below, we take a look at the new manufacturing agreement that appears to be spurring investor interest in the ASX medicinal cannabis company.

What new manufacturing agreement was announced?

Epsilon Healthcare’s share price is soaring after the company reported it has executed a binding term sheet and manufacturing agreement with Cannim Australia Pty Ltd.

Cannim, established in 2017, cultivates cannabis in Jamaica and Australia. The privately held company has engaged Epsilon as its Australian GMP manufacturing partner.

Epsilon’s Southport Facility in Queensland will produce medicinal cannabis products from marijuana supplied by Cannim for supply into Australian and global export. Epsilon will receive payment from Cannim for its manufacturing services on a per-order basis

The initial agreement runs for 2 years.

According to the release, the first cannabis derived dried flower products have already been delivered and are available to patients by Epsilon under Cannim’s HummingBud brand.

Under the binding term sheet, the companies have agreed to further collaboration and manufacture over next 2 years.

Management commentary

Commenting on the agreement, Epsilon Healthcare CEO Jarrod White said:

Matching our high-volume EU GMP compliant Southport Facility with Cannim’s high volume GACP Jamaican medicinal cannabis places both companies in a strong position to deliver significant volumes of high-quality medicines for both the Australian and global export markets.

The partnership contemplates all areas of the Epsilon value chain, from local import and handling of dried product expertise, to export, and assisting in the logistics and distribution of the final product. This is reflective of the significant progress and capability improvements at our Southport facility in the preceding 12 months.

Epsilon Healthcare share price snapshot

Despite today’s big boost, the Epsilon Healthcare share price remains down 36% year-to-date. By comparison the All Ordinaries Index (ASX: XAO) is up 12% so far in 2020.

The last month has been kinder to Epsilon Healthcare shareholders, with shares up 19% since 21 September.

The post Epsilon Healthcare (ASX:EPN) share price rockets 24% on new agreement appeared first on The Motley Fool Australia.

More reading

• Why the BrainChip (ASX:BRN) share price is rocketing 15% today
• Why Robinhood Should Worry About PayPal’s New Payments App
• Why AMP, Aristocrat, Brainchip, and Healius shares are racing higher
• Santos (ASX:STO) share price wobbles despite record quarterly sales revenue
• A2 Milk (ASX:A2M) share price drops amid reported second class action

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3aUeOv9

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At the time of writing, the benchmark index is up 0.35% to 7,438.9 points.

Four ASX shares that are climbing more than most are listed below. Here’s why they are racing higher:

AMP Ltd (ASX: AMP)

The AMP share price is up 3.5% to $1.16. Investors have been buying the financial services company’s shares following the release of its third quarter update. According to the release, the AMP Capital business saw its assets under management (AUM) fall by $7.3 billion. However, this was largely due to the previously announced exit of the NZ wealth management (NZWM) mandate of $9.2 billion. Positively, average Australian Wealth Management AUM increased $3.7 billion to $132.4 billion.

Aristocrat Leisure Limited (ASX: ALL)

The Aristocrat Leisure share price is up 4.5% to $47.85. Investors have been buying the gaming technology company’s shares following the successful completion of the institutional component of its $1.3 billion entitlement offer. The company also revealed that a bookbuild for institutional entitlement offer shortfall shares cleared at a price of $47.10 per new share. This represents a premium of $5.25 to the offer price and a 2.8% premium to the Aristocrat share price prior to its trading halt. Aristocrat is raising funds to acquire London-listed leading global online gambling software and content supplier, Playtech, for $5 billion.

Brainchip Holdings Ltd (ASX: BRN)

The Brainchip share price is up 9% to 48.5 cents. This follows the release of a few announcements by the artificial technology company. One of those reveals that it has now started to take orders for its Akida AI Processor Development Kits. Though, it is unclear if any orders have been received. In addition, the company was granted a patent in the US. The patent is for spontaneous machine learning and feature extraction.

Healius Ltd (ASX: HLS)

The Healius share price is up 7% to $4.87. This follows the release of a first quarter update which revealed explosive sales and earnings growth thanks to strong demand for COVID-19 testing. Healius advised that its first quarter revenue increased 43.7% to $689.9 million and its underlying EBIT grew 159% to $201.9 million. The company revealed it was averaging 40,000 COVID tests per working day during the period.

The post Why AMP, Aristocrat, Brainchip, and Healius shares are racing higher appeared first on The Motley Fool Australia.

More reading

• Why the BrainChip (ASX:BRN) share price is rocketing 15% today
• ASX 200 (ASX:XJO) midday update: Aristocrat hits record high, Flight Centre sinks
• Healius (ASX:HLS) share price jumps 7% following huge Q1 earnings growth
• AMP (ASX:AMP) share price gains 3% despite FUM falling by $7b
• Aristocrat (ASX:ALL) share price jumps 8% to record high after raising $895m

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3vxyi2b

The Santos Ltd (ASX: STO) share price is currently edging lower after a rollercoaster day so far, down 0.27% to $7.26 per share. It jumped as high as $7.32 at open then slumped to $7.21 before regaining some ground.

Below we take a look at the S&P/ASX 200 Index (ASX: XJO) energy company’s quarterly update for the period ending 30 September.

What were Santos’ Q3 highlights?

The Santos share price is edging lower despite the company reporting record quarterly sales revenue of US$1.14 billion, a 6% increase from Q2 figures.

Santos’ quarterly free cash flow also reached a new record, increasing by 33% from the previous quarter to US$359 million.

The company credited the record results to the lift in commodity prices during the reporting period along with its own “strong base business performance”.

As at the end of September, Santos had brought down its net debt, including leases, to US$3.1 billion and gearing dropped to 29.7%. At current commodity prices, Santos said it expects gearing to be less than 28% by the end of the year.

In the biggest news for the company during Q3, Santos and Oil Search Ltd (ASX: OSH) entered into a definitive agreement in September to merge the two companies in an all-scrip transaction.

Commenting on the merger, Santos CEO Kevin Gallagher said:

The proposed merger with Oil Search is on track for completion by year-end, subject to customary conditions including Oil Search shareholder approval. I’m very happy with how the merger is progressing, and particularly acknowledge the positive comments from PNG Prime Minister Hon. James Marape, at what is an incredibly important time for energy markets and energy companies around the world.

Size and scale have never been more important as we look to fund the energy transition to net-zero emissions, and the merger is expected to create one of the top-20 companies in our sector globally and a top-20 ASX-listed company.

The updated 2021 guidance doesn’t appear to have done much for the Santos share price. The company is maintaining production guidance, but boosting it to the upper end of its earlier forecast range. Production cost guidance, meanwhile, was reduced to the lower end of the earlier forecast.

Santos share price snapshot

The Santos share price has outperformed over the past 12 months, up 40% compared to a gain of 20% posted by the ASX 200 during that same time.

Over the past month, Santos shares are up 17%.

The post Santos (ASX:STO) share price wobbles despite record quarterly sales revenue appeared first on The Motley Fool Australia.

More reading

• This leading fund manager thinks these ASX shares might be buys
• 5 things to watch on the ASX 200 on Monday
• 5 things to watch on the ASX 200 on Friday
• Top broker tips Santos (ASX:STO) share price to climb 17%
• Santos (ASX:STO) share price slumps as CEO flags possible energy crisis

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3b1qgos

The A2 Milk Company Ltd (ASX: A2M) share price is currently down amid news of a second class action against the company.

Another class action?

The company announced to the ASX that it’s aware of media reporting about a potential class action against the company that is apparently being investigated by Shine Justice Ltd (ASX: SHJ).

However, A2 Milk said it’s not aware of any legal proceeding having been filed by Shine Lawyers.

The company noted again that it believes it has, at all times, complied with disclosure obligations, denies any liability and will vigorously defend against any proceedings. It said it will respond further if and when any legal action is launched.

What are the allegations by Shine Lawyers?

The class action by Shine alleges that between 19 August 2020 and 7 May 2021, A2 Milk engaged in “misleading and deceptive” conduct, breaching its continuous disclosure obligations, and failing to adequately disclose future trade plans.

Shine also alleges that by 19 August 2020, A2 Milk was, or ought to have been aware that the FY21 guidance, and subsequent announcements, did not adequately take into account a number of factors known to the company which ultimately impacted the company’s financial performance. This led to a 62% drop in the A2 Milk share price.

There were two factors that A2 Milk referred to.

First, the decline in reseller/daigou sales, which reportedly fell due to the impact of A2 Milk’s sales through its cross border e-commerce channel. Shine noted that this saw A2 Milk heavily market English-labelled infant products directly into the Chinese market with discounting that “effectively undercut” sales in the daigou/reseller channel.

Second, Shine also referred to the decline in the CBEC business due to the drop in the daigou/reseller sales. Shine said that daigou sales often help stimulate demand for direct orders.

Two class actions

This is the second class action that A2 Milk is facing.

The lawyer group Slater & Gordon Limited (ASX: SGH) has also launched a class action. This occurred earlier in October.

Shine’s class action alleges similar sorts of things that the Slater & Gordon one does.

Slater & Gordon said:

The proceeding alleges that by no later than 19 August 2020, A2 Milk was or ought to have been aware that the FY21 guidance and subsequent representations did not adequately take account of a number of factors which would impact the company’s financial performance.

What is the latest guidance from A2 Milk?

FY21 has finished, but guidance for FY22 can have an impact on the A2 Milk share price.

In its FY21 result, A2 Milk said that its revenue fell 30.3% to $1.21 billion and net profit after tax (NPAT) had dropped 79.1% to $80.7 million.

Whilst the company said it wasn’t going to provide specific guidance, it said that it’s confident in the underlying fundamentals of the business and that the growth opportunity in core markets remains “significant”. The company also said there are opportunities for product innovation, category expansion and new markets. It said the long-term outlook is positive.

However, it also said that there is continuing uncertainty and volatility in consumer markets due to COVID-19, and other rapidly changing market dynamics, particularly in China.

The post A2 Milk (ASX:A2M) share price drops amid reported second class action appeared first on The Motley Fool Australia.

More reading

• Why A2 Milk, Adairs, Bapcor, and Kogan shares are racing higher
• A2 Milk (ASX:A2M) share price ticks higher as UBS increases holding
• 3 punished ASX shares that could come roaring back
• Top brokers name 3 ASX shares to sell next week
• These were the best performing ASX 200 shares last week

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3ngUVUA

The Apollo Consolidated Ltd (ASX: AOP) share price has rocketed into the green today, currently trading more than 10% higher at 58.5 cents apiece.

That’s an all-time high for the West Australian gold and minerals explorer, which has been under the spotlight lately as competition surfaces between two ASX gold rivals to acquire the company.

Read on for more details.

What did Apollo announce today?

Apollo advised it had received an unconditional, off-market takeover bid from Gold Road Resources Ltd (ASX: GOR) to acquire all of the outstanding Apollo shares it does not already own.

The Gold Road proposal comes just a few days after another ASX gold share, Ramelius Resources Ltd (ASX: RMS), made an offer to acquire the company.

Ramelius has put forward a conditional, cash and scrip deal that implies a share price value of 55.4 cents for Apollo.

Meanwhile, Gold Road is offering an all-cash consideration of 56 cents per share – a 2.5% discount to Apollo’s current share price.

Importantly, Gold Road’s bid values Apollo at $166 million on a fully diluted basis, whereas Ramelius’ offer sets a valuation of $163 million.

What’s next for Apollo?

After receiving the first offer, Apollo’s board unanimously recommended its shareholders vote in favour of the Ramelius proposal.

In response to Gold Road’s proposal today, the board has recommended its shareholders take no immediate action. This will enable Apollo to analyse both offers over the next month and decide which fits best for the company.

Apollo stated in today’s release:

Apollo reiterates that shareholders should TAKE NO ACTION in respect of the Gold Road offer until they have had the opportunity to fully consider both Apollo’s target’s statement and the bidder’s statement.

As the Gold Road offer must remain open for at least one calendar month from its commencement, Apollo shareholders will have ample time to make a decision after they have received the target’s statement.

Apollo share price snapshot

The Apollo share price has boasted an outsized return this year, gaining 89% since January 1.

This extends its return over the last year to 56%, well ahead of the S&P/ASX 200 index (ASX: XJO)’s gain of around 19% in that time.

The post Apollo (ASX:AOP) share price leaps 10% on takeover news appeared first on The Motley Fool Australia.

More reading

• Gold Road (ASX:GOR) share price edges higher on acquisition news

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3E6wjoB

The Rio Tinto Limited (ASX: RIO) share price is in the red today despite the company getting a little greener.

At the time of writing, shares in the mining giant are trading for $97.69 – down 0.4%. For context, the S&P/ASX 200 Index (ASX: XJO) is 0.31% higher.

The Rio Tinto share price is in focus today as the miner announces plans to halve its scope 1 and 2 emissions by 2030.

Let’s take a closer look at today’s news.

Rio Tinto share price dips despite “ambitious” climate policies

In a statement to the ASX, Rio Tinto says it is “tripling” its previous emissions reduction target.

On top of halving its direct emissions by 2030, the miner says it will achieve a 15% reduction by 2025. This is 5 years earlier than anticipated.

Rio says these “ambitious” targets are supported by about $7.5 billion in direct investments to lower emissions between 2022 and 2030.

Rio Tinto will also “prioritise growth capital” in commodities vital for this transition, such as copper and nickel, with an ambition to double growth capex to about $3 billion a year from 2023.

Despite this, the Rio Tinto share price is slightly down.

What are Scope 1 and 2 emissions?

For clarity, according to the Australian Government, scope 1 emissions are caused directly by a company’s activities. For example, the driving of trucks up and down a mine. Scope 2 emissions are indirect and caused by a company’s operations. An example of this for Rio Tinto would be using electricity sourced from fossil fuels to power its mines.

Scope 3 emissions result from either a company’s supply chain or how the company’s products are used. For example, the emissions caused by the manufacturing of steel that uses Rio-mined iron ore.

Scope 3 emissions are not part of Rio’s commitments. However, the company will “accelerate its investment in R&D and development of technologies that enable its customers to decarbonise”.

What did management say?

Rio Tinto Chief Executive, Jakob Stausholm, said:

Rio Tinto is taking action to strengthen our business and improve our performance by unleashing the full potential of our people and assets, working in partnership with a broad range of stakeholders.

All our commodities are vital for the energy transition and continue to benefit from ongoing urbanisation.

We have a clear pathway to decarbonise our business and are actively developing technologies that will enable our customers and our customers’ customers to decarbonise.

We are able to do this, while continuing to provide attractive returns to our shareholders in line with our policy, because we have a strong balance sheet and world-class assets that deliver strong free cash flows through the cycle.

Rio Tinto share price snapshot

Over the past 12 months, the Rio Tinto share price has increased 2.4%. Year to date, Rio shares have plummeted 15.4%, largely due to the recently falling iron ore price.

Its 52-week high is $137.33 and its 52-week low is $90.04. Rio has a market capitalisation of approximately $151 billion.

The post Rio Tinto (ASX:RIO) share price dips amid pledge to halve direct emissions by 2030 appeared first on The Motley Fool Australia.

More reading

• These are the 5 highest yielding dividend stocks in the ASX 200
• Leading brokers name 3 ASX shares to sell today
• Top broker says Rio Tinto (ASX:RIO) share price is a buy and could rise 21%
• 5 things to watch on the ASX 200 on Monday
• ASX 200 (ASX:XJO) midday update: Rio Tinto cuts guidance, Treasury Wine disappoints

Motley Fool contributor Marc Sidarous has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/30NgCUP